Take the first step towards a healthier you with CKE Rejuvenation
Recent studies indicate that Tirzepatide and Semaglutide are the most effective GLP-1 receptor agonists for weight loss, with significant results in clinical trials
We expect the number of cases in this MDL to continue to steadily rise as waves of new patients begin to take the drug without Novo Nordisks warning of potential harmful side effects such as stomach paralysis, bowel obstruction, and blindness
At the same time, compounded drugs are not FDA-approved, meaning the agency has not evaluated them for safety, effectiveness, or quality prior to marketing
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of beta-amyloid pathology
Kathleen Valenton, MD, is a Lemme advisory board member